XORTX Therapeutics (XRTX) Change in Intangibles (2020 - 2026)
XORTX Therapeutics (XRTX) posted Change in Intangibles of -$3788.0 for Q1 2026, up 84.56% on a QoQ basis from -$24527.0 in Q4 2025, and down 11.91% year-over-year from -$4299.9 in Q1 2025.
XORTX Therapeutics (XRTX) Change in Intangibles (2020 - 2026) Analysis & Trends
XORTX Therapeutics' Change in Intangibles history runs 7 years deep, the most recent figure standing at -$3788.0 for Q1 2026.
- Quarterly Change in Intangibles fell 11.91% year-over-year to -$3788.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$55626.0 (down 245.76% YoY) and the FY2025 annual result came in at -$55223.0, down 241.87% from the prior year.
- Change in Intangibles was -$3788.0 for Q1 2026 at XORTX Therapeutics, up from -$24527.0 in the prior quarter.
- Across five years, Change in Intangibles topped out at $74310.0 in Q4 2023 and bottomed at -$24527.0 in Q4 2025.
- A 5-year average of -$238.32 and a median of -$6860.6 in 2022 frame the typical range for Change in Intangibles.
- Annual changes were most pronounced in 2022 — Change in Intangibles tumbled 1695.36% — and 2023, when it soared 752.32%.
- XORTX Therapeutics' Change in Intangibles stood at -$11391.6 in 2022, then surged by 752.32% to $74310.0 in 2023, then dropped by 0.67% to $73812.0 in 2024, then slumped by 133.23% to -$24527.0 in 2025, then surged by 84.56% to -$3788.0 in 2026.
- Business Quant data shows XRTX's Change in Intangibles at -$3788.0 in Q1 2026, -$24527.0 in Q4 2025, and -$5486.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -66,508.31 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | XORTX Therapeutics | 20.40 Mn | 20.40 Mn | - | -3,788.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,788.00 |
| Mar 31, 2026 | -3,788.00 |
| Dec 31, 2025 | -24,527.00 |
| Dec 31, 2025 | -24,527.00 |
| Sep 30, 2025 | -5,486.00 |
| Sep 30, 2025 | -5,486.00 |
| Jun 30, 2025 | -21,825.00 |
| Jun 30, 2025 | -21,825.00 |
| Mar 31, 2025 | -3,385.00 |
| Mar 31, 2025 | -3,385.00 |
| Dec 31, 2024 | 73,812.00 |
| Dec 31, 2024 | 73,812.00 |
| Sep 30, 2024 | -23,181.00 |
| Sep 30, 2024 | -23,181.00 |
| Jun 30, 2024 | -9,084.00 |
| Jun 30, 2024 | -9,084.00 |
| Mar 31, 2024 | -2,623.00 |
| Mar 31, 2024 | -2,623.00 |
| Dec 31, 2023 | 74,310.00 |
| Dec 31, 2023 | 74,310.00 |